Μετάβαση στο περιεχόμενο

ΕτικέταNovo Nordisk

Evotec and Novo Nordisk Ink Deal to Develop Drugs for Obesity and Diabetes

Months after partnering with Sanofi on infectious diseases, Germany-based Evotec has formed another significant partnership with Novo Nordisk. The two companies will combine their forces to develop treatments for diabetes, nonalcoholic steatohepatitis (NASH) and other diseases. Evotec … Continue Reading Evotec and Novo Nordisk Ink Deal to Develop Drugs for Obesity and Diabetes